Is Acasti Pharma Inc (ACST) a leader in the biotechnology industry?


A rating of 94 places Acasti Pharma Inc (ACST) near the top of the biotechnology industry according to Investors Observer. Acasti Pharma Inc’s score of 94 means it scores over 94% of industry stocks. Acasti Pharma Inc also received an overall rating of 62, placing it above 62% of all stocks. Biotechnology is ranked 91st out of 148 industries.

ACST has an overall score of 62. Find out what that means to you and get the rest of the rankings on ACST!

What do these notes mean?

Analyzing inventory can be difficult. There are tons of numbers and ratios out there, and it can be hard to remember what they all mean and what counts as “good” for a given value. Investors Observer ranks stocks according to eight different measures. We rank most of our scores in percentiles to make it easier for investors to understand. A score of 62 means the stock is more attractive than 62% of the stock. These rankings allow you to easily compare stocks and see what are the strengths and weaknesses of a particular business. This allows you to find stocks with the best prospects for short and long term growth in seconds. The combined score incorporates technical and fundamental analysis to give a comprehensive overview of a stock’s performance. Investors who then want to focus on rankings or analysts’ ratings can see separate scores for each section.

What is happening with the shares of Acasti Pharma Inc today?

Acasti Pharma Inc (ACST) stock is trading at $ 1.25 at 1:39 p.m. on Tuesday, December 28, a loss of – $ 0.09, or -6.72% from the previous closing price of 1 , $ 34. The stock has traded between $ 1.22 and $ 1.37 so far today. The volume today is low. So far, 1,642,392 shares have been traded for an average volume of 2,501,800 shares. Click here for the full share report of Acasti Pharma Inc.


Comments are closed.